Strokes can be
classified as either ischemic or hemorrhagic, where an ischemic stroke is
characterized by failure in proper blood supply to a part of brain due to
blockage (due to blood clots or arthrosclerosis) created in the blood vessel.
These blood clots have the ability of travelling to brain either from heart
(cardioemblic stroke) or from another artery (artery-to-artery
embolization).
Acute ischemic strokes can be caused by building up fatty
materials along the walls of artery, breaking off atheroma from the artery wall
and getting stuck in a smaller artery, blood clots which break loose from heart
valves also known as embolus, inflammation or infection to an artery, drugs
like cocaine and amphetamines which narrow the blood vessels and sudden drop in
blood pressure. According to the WHO,each year 15 million people suffer from
stroke worldwide. The global acute ischemic stroke treatment market can be
segmented on the basis of drug treatmentsand surgical procedures.
Browse
Full Report with TOC: http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html
Acute ischemic stroke
(AIS) treatment marketis driven by aging population which has higher incidence
of AIS.Other drivers of this market include recent launch of novel new
generation drugs, growing research investments andincreasing prominence of
telemedicine.A major growth avenue in this market opened with the launch of
Desmoteplase, a novel next-generation thrombolytic, which has an extended
therapeutic time window when compared with the current standard of care.
North America is
considered to be the largest AIS treatment market because of highest prevalence
and incidence of AIS and comparatively high AIS therapy cost in this region. In
the United States, AIS is the third leading cause of death as well as one of
the leading causes of disability. Europe is second largest market for AIS
treatment as the major countries such as the U.K., Germany, Spain and Italy
have the highest prevalence and incidence of AIS from this region. Asia-Pacific
market is considered to be the most attractive market for AIS. Some of the key
players of this market include Bayer, Bristol-Myers Squibb,
BoehringerIngelheim, Lundbeck, ThromboGenics, Vernalis and Others.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends.
Geographies
analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons for Buying this
Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
- It helps in understanding the key
product segments and their future
- It provides pin point analysis of
changing competition dynamics and keeps you ahead of competitors
More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us:-
Transparency Market Research (TMR) is a
market intelligence company providing global business research reports and
consulting services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources along with various
tools and techniques to gather and analyze information. Our business offerings
represent the latest and the most reliable information which is indispensable
for businesses to sustain their competitive edge.
Our data repository is continuously
updated and revised by a team of research experts so that it always reflects
the latest trends and information. With broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for
business reports.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
http://marketingresearchreport.blogspot.com
No comments:
Post a Comment